3-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea
C18H23N9O2 — CID 122184947
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea
3-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea (PubChem CID 122184947) has the molecular formula C18H23N9O2 and a molecular weight of 397.44 g/mol. Its IUPAC name is 3-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea.
Molecular Properties
| Compound Name | 3-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea |
|---|---|
| PubChem CID | 122184947 |
| Molecular Formula | C18H23N9O2 |
| Molecular Weight | 397.44 g/mol |
| Exact Mass | 397.20 |
| IUPAC Name | 3-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea |
| SMILES | CN(C)C(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12 |
| InChI | InChI=1S/C18H23N9O2/c1-25(2)18(28)22-11-13-3-4-14-16(26-5-7-29-8-6-26)23-15(24-27(13)14)12-9-20-17(19)21-10-12/h3-4,9-10H,5-8,11H2,1-2H3,(H,22,28)(H2,19,20,21) |
| InChIKey | PGRZZPIJRSXMGA-UHFFFAOYSA-N |
| XLogP | 0.38 |
| TPSA | 126.80 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 397.44 |
| LogP ≤ 5 | 0.38 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122184947 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.